首页> 外国专利> Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects

Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects

机译:对肠胃外和吸入剂量有抵抗力且副作用减少的镇痛剂型

摘要

The invention provides a novel solid pharmaceutical dosage form which includes an opiate, an opiate antagonist admixed with the analgetic (opiate agonist) and an amount of a hydrocolloid containing excipient which is effective to form a non-injectable slurry when the dosage form is contacted with water. In addition the dosage form contains pure naloxone in enteric coated form which is designed to release in the colon to prevent or relieve constipation. Thus the formulation, because of the enteric coated naloxone and the hydrocolloid excipient(s), has reduced side effects as compared with formulations which do not contain these features.
机译:本发明提供了一种新颖的固体药物剂型,其包含鸦片,与止痛剂(鸦片激动剂)混合的鸦片拮抗剂和一定量的含有水胶体的赋形剂,当该剂型与之接触时可有效形成不可注射的浆液。水。另外,剂型包含肠溶衣形式的纯纳洛酮,其被设计成在结肠中释放以预防或缓解便秘。因此,与不包含这些特征的制剂相比,由于肠溶性纳洛酮和水胶体赋形剂,该制剂具有减少的副作用。

著录项

  • 公开/公告号US2005165038A1

    专利类型

  • 公开/公告日2005-07-28

    原文格式PDF

  • 申请/专利权人 MAXWELL GORDON;

    申请/专利号US20040762714

  • 发明设计人 MAXWELL GORDON;

    申请日2004-01-22

  • 分类号A61K31/485;A61K9/14;

  • 国家 US

  • 入库时间 2022-08-21 22:23:13

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号